Skip to main content

Table 1 Clinicopathological data of the IDH mutant versus wild-type group

From: IDH1 or -2 mutations do not predict outcome and do not cause loss of 5-hydroxymethylcytosine or altered histone modifications in central chondrosarcomas

  IDH wild-type (n = 29) IDH mutation (n = 45)
Male 9 (31%) 19 (42%)
Median age at diagnosis 51 (21–79) 51 (22–85)
Histology
 Enchondroma 1 (15%) 6 (85%)
 ACT/grade I 14 (50%) 14 (50%)
 Grade II 9 (34%) 18 (66%)
 Grade III 5 (42%) 7 (58%)
 Metastasis 4 (45%) 5 (55%)
Median follow-up (months) 137 (7–278) 121 (11–312)
  1. ACT atypical cartilaginous tumour